These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 12434728)
1. Which weight for weight-based dosage regimens in obese patients? Erstad BL Am J Health Syst Pharm; 2002 Nov; 59(21):2105-10. PubMed ID: 12434728 [No Abstract] [Full Text] [Related]
2. Dosing in obesity: a simple solution to a big problem. Han PY; Duffull SB; Kirkpatrick CM; Green B Clin Pharmacol Ther; 2007 Nov; 82(5):505-8. PubMed ID: 17952107 [TBL] [Abstract][Full Text] [Related]
3. Drug disposition in obesity: toward evidence-based dosing. Knibbe CA; Brill MJ; van Rongen A; Diepstraten J; van der Graaf PH; Danhof M Annu Rev Pharmacol Toxicol; 2015; 55():149-67. PubMed ID: 25340929 [TBL] [Abstract][Full Text] [Related]
4. The effects of obesity on drug pharmacokinetics in humans. Morrish GA; Pai MP; Green B Expert Opin Drug Metab Toxicol; 2011 Jun; 7(6):697-706. PubMed ID: 21417960 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic considerations in the obese. Leykin Y; Miotto L; Pellis T Best Pract Res Clin Anaesthesiol; 2011 Mar; 25(1):27-36. PubMed ID: 21516911 [TBL] [Abstract][Full Text] [Related]
6. Allometric size: The scientific theory and extension to normal fat mass. Holford NHG; Anderson BJ Eur J Pharm Sci; 2017 Nov; 109S():S59-S64. PubMed ID: 28552478 [No Abstract] [Full Text] [Related]
7. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults. Pai MP Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238 [TBL] [Abstract][Full Text] [Related]
8. Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing. Kendrick JG; Carr RR; Ensom MH Clin Ther; 2015 Sep; 37(9):1897-923. PubMed ID: 26361823 [TBL] [Abstract][Full Text] [Related]
9. Lean body mass as a predictor of drug dosage. Implications for drug therapy. Morgan DJ; Bray KM Clin Pharmacokinet; 1994 Apr; 26(4):292-307. PubMed ID: 8013162 [TBL] [Abstract][Full Text] [Related]
10. Lean-scaled weight: a proposed weight scalar to calculate drug doses for obese patients. Friesen JH Can J Anaesth; 2013 Feb; 60(2):214-5. PubMed ID: 23192695 [No Abstract] [Full Text] [Related]
11. A standard weight descriptor for dose adjustment in the obese patient. Duffull SB; Dooley MJ; Green B; Poole SG; Kirkpatrick CM Clin Pharmacokinet; 2004; 43(15):1167-78. PubMed ID: 15568893 [TBL] [Abstract][Full Text] [Related]
12. [Posology of drugs in the obese patient]. Biollaz J; Schelling JL Ther Umsch; 1987 Aug; 44(8):601-6. PubMed ID: 3313790 [No Abstract] [Full Text] [Related]
13. Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients. Chung EK; Cheatham SC; Fleming MR; Healy DP; Kays MB J Clin Pharmacol; 2017 Mar; 57(3):356-368. PubMed ID: 27530916 [TBL] [Abstract][Full Text] [Related]
14. [The effect of age, weight, sex and smoking habits on drug dosage]. Ochs HR; Verburg-Ochs B Internist (Berl); 1983 Mar; 24(3):167-81. PubMed ID: 6347943 [No Abstract] [Full Text] [Related]
15. [Drug dosing in overweight and underweight]. Raknes G; Schjøtt JD Tidsskr Nor Laegeforen; 2008 Aug; 128(16):1843-4. PubMed ID: 18787597 [No Abstract] [Full Text] [Related]
19. Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients. Chung EK; Cheatham SC; Fleming MR; Healy DP; Shea KM; Kays MB J Clin Pharmacol; 2015 Aug; 55(8):899-908. PubMed ID: 25823963 [TBL] [Abstract][Full Text] [Related]
20. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach. Mahmood I Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]